125 related articles for article (PubMed ID: 20007955)
1. Predicting the response to infliximab from trough serum levels.
Rutgeerts P; Vermeire S; Van Assche G
Gut; 2010 Jan; 59(1):7-8. PubMed ID: 20007955
[No Abstract] [Full Text] [Related]
2. Comment on 'Predicting the response to infliximab from trough serum levels'.
Bendtzen K; Steenholdt C; Ainsworth M; Thomsen OØ; Brynskov J
Gut; 2010 Sep; 59(9):1298-9; author reply 1299-300. PubMed ID: 20801776
[No Abstract] [Full Text] [Related]
3. Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis.
Seow CH; Newman A; Irwin SP; Steinhart AH; Silverberg MS; Greenberg GR
Gut; 2010 Jan; 59(1):49-54. PubMed ID: 19651627
[TBL] [Abstract][Full Text] [Related]
4. Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis.
Adedokun OJ; Sandborn WJ; Feagan BG; Rutgeerts P; Xu Z; Marano CW; Johanns J; Zhou H; Davis HM; Cornillie F; Reinisch W
Gastroenterology; 2014 Dec; 147(6):1296-1307.e5. PubMed ID: 25173754
[TBL] [Abstract][Full Text] [Related]
5. Editorial: prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis.
Hendy P; Hart A
Aliment Pharmacol Ther; 2015 Jan; 41(1):149. PubMed ID: 25483435
[No Abstract] [Full Text] [Related]
6. Infliximab in ulcerative colitis.
Böcker U
Scand J Gastroenterol; 2006 Sep; 41(9):997-1000. PubMed ID: 16938710
[No Abstract] [Full Text] [Related]
7. Infliximab for refractory ulcerative proctitis.
Bouguen G; Roblin X; Bourreille A; Feier L; Filippi J; Nancey S; Bretagne JF; Flourié B; Hébuterne X; Bigard MA; Siproudhis L; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2010 Jun; 31(11):1178-85. PubMed ID: 20222911
[TBL] [Abstract][Full Text] [Related]
8. Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula.
Hassan C; Zullo A; Ierardi E; Burattini O; De Francesco V; Morini S
Gut; 2006 Apr; 55(4):589-90. PubMed ID: 16531548
[No Abstract] [Full Text] [Related]
9. Sacroileitis and peripheral arthropathy associated with ulcerative colitis: effect of infliximab on both articular and intestinal symptoms.
Lupascu A; Armuzzi A; De Pascalis B; Carloni E; Lauritano EC; Gasbarrini A; Pola P; Gasbarrini A
Dig Liver Dis; 2004 Jun; 36(6):423-5. PubMed ID: 15248384
[TBL] [Abstract][Full Text] [Related]
10. Infliximab or cyclosporine for severe ulcerative colitis.
Hanauer SB
Gastroenterology; 2005 Oct; 129(4):1358-9; author reply 1359. PubMed ID: 16230092
[No Abstract] [Full Text] [Related]
11. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
Jakobovits SL; Jewell DP; Travis SP
Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506
[TBL] [Abstract][Full Text] [Related]
12. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
13. Infliximab in refractory severe ulcerative colitis: a case report.
Bossa F; Caserta L; Selvaggi F; Riegler G
Minerva Gastroenterol Dietol; 2005 Sep; 51(3):261-2. PubMed ID: 16280968
[No Abstract] [Full Text] [Related]
14. Infliximab therapy for ulcerative colitis: many unanswered questions.
Present DH
Am J Gastroenterol; 2001 Aug; 96(8):2294-6. PubMed ID: 11513164
[No Abstract] [Full Text] [Related]
15. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
Yamamoto-Furusho JK; Uzcanga LF
Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
[TBL] [Abstract][Full Text] [Related]
16. [Adapting the dose to the residual concentration of infliximab in cryptogenic inflammatory diseases of the intestines].
Chanson P; Pariente A
Rev Prat; 2015 Apr; 65(4):473. PubMed ID: 26058185
[No Abstract] [Full Text] [Related]
17. Infliximab for refractory ulcerative colitis.
Chey WY; Hussain A; Ryan C; Potter GD; Shah A
Am J Gastroenterol; 2001 Aug; 96(8):2373-81. PubMed ID: 11513177
[TBL] [Abstract][Full Text] [Related]
18. Infliximab rescue therapy in ulcerative colitis, and the effect on subsequent colectomy rates.
Halpin SJ; Hamlin PJ; Ford AC
Aliment Pharmacol Ther; 2010 Nov; 32(10):1294-5. PubMed ID: 20955450
[No Abstract] [Full Text] [Related]
19. Infliximab or cyclosporine for severe ulcerative colitis.
Järnerot G
Gastroenterology; 2006 Jan; 130(1):286; author reply 287. PubMed ID: 16401502
[No Abstract] [Full Text] [Related]
20. Infliximab rescue therapy in steroid-refractory ulcerative colitis: is more really more?
Molnár T; Farkas K; Szepes Z; Nagy F; Wittmann T
Aliment Pharmacol Ther; 2011 Feb; 33(3):412-3. PubMed ID: 21198699
[No Abstract] [Full Text] [Related]
[Next] [New Search]
